Skip to Main Content
TRC_Tech_Canada
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • NetCE All Access: Behaviorial Health
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Natural Medicines Resources
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • Do Not Crush List
    • New Drugs
    • Original Container Meds
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

  1. Home
  2. Browse
  3. Bone & Joint
  4. Osteoporosis
  5. Treatment

Treatment

  • Fibromyalgia (21)
  • Fractures (7)
  • Gout (19)
  • Lupus (5)
  • Musculoskeletal (15)
  • Orthopedics (8)
  • Osteoarthritis (58)
  • Osteopathy (2)
  • Osteoporosis (160)
    • Bisphosphonates (15)
    • Drug Toxicity (31)
    • Natural Medicines/Supplements (22)
    • Prevention/Screening (30)
    • Treatment (37)
  • Other (17)
  • Resources (115)
  • Rheumatoid Arthritis (60)
16 - 30 of 37 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Patient Education: Lo que necesito saber sobre mi Bifosfonatos July 2013
Commentary: Osteoporosis in Men September 2012
Article: more emphasis on treating osteoporosis in MEN September 2012
Article: more opportunities to prevent mix-ups with osteoporosis meds July 2012
Commentary: Safety of Long-Term Bisphosphonate Therapy November 2011
Guideline: Prevention and Treatment of Osteoporosis (NOF) (2013) August 2010
Guideline: Management of Osteoporosis in Postmenopausal Women (NAMS) (2010) August 2010
Commentary: New Drug: Prolia (Denosumab) August 2010
Guideline: Diagnosis and Treatment of Osteoporosis (ICSI) (Updated July 2013) August 2010
Guideline: American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Prevention and Treatment Of Postmenopausal Osteoporosis: 2001 Edition, with Selected Updates for 2003 December 2009
Guideline: Menopause and Osteoporosis Update (Canadian) (2009) December 2009
Guideline: Prevention and Treatment of Osteoporosis (NOF) (2013) December 2009
Guideline: 2010 NAMS Position Statement on the Management of Osteoporosis in Postmenopausal Women December 2009
Guideline: Diagnosis and Treatment of Osteoporosis (ICSI) (Updated July 2013) December 2009
Commentary: Summary of the Latest Guidelines on Bisphosphonate-Induced Osteonecrosis March 2009
  • « Prev
  • 1
  • 2
  • 3
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved